MADISON, Wis. (AP) _ Exact Sciences Corp. (EXAS) on Thursday reported a loss of $86.1 million in its second quarter.
The Madison, Wisconsin-based company said it had a loss of 58 cents per share.
The results beat Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of 62 cents per share.
The molecular diagnostics company posted revenue of $268.9 million in the period, also beating Street forecasts. Seven analysts surveyed by Zacks expected $229.6 million.
Exact Sciences shares have risen roughly 6% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $97.90, a decline of 17% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EXAS at https://www.zacks.com/ap/EXAS
© 2020 The Canadian Press. All rights reserved., source Canadian Press DataFile